...
首页> 外文期刊>Glycobiology. >alpha1,3Fucosyltransferase VI is expressed in HepG2 cells and codistributed with beta1,4galactosyltransferase I in the golgi apparatus and monensin-induced swollen vesicles.
【24h】

alpha1,3Fucosyltransferase VI is expressed in HepG2 cells and codistributed with beta1,4galactosyltransferase I in the golgi apparatus and monensin-induced swollen vesicles.

机译:alpha1,3Fucosyltransferase VI在HepG2细胞中表达,并与高尔基体和莫能菌素诱导的囊泡中的beta1,4半乳糖基转移酶I共分布。

获取原文
获取原文并翻译 | 示例
           

摘要

The major alpha1,3fucosyltransferase activity in plasma, liver, and kidney is related to fucosyltransferase VI which is encoded by the FUT6 gene. Here we demonstrate the presence of alpha1, 3fucosyltransferase VI (alpha3-FucT VI) in the human HepG2 hepatoma cell line by specific activity assays, detection of transcripts, and the use of specific antibodies. First, FucT activity in HepG2 cell lysates was shown to prefer sialyl-N-acetyllactosamine as acceptor substrate indicating expression of alpha3-FucT VI. RT-PCR analysis further confirmed the exclusive presence of the alpha3-FucT VI transcripts among the five human alpha3-FucTs cloned to date. alpha3-FucT VI was colocalized with beta1,4galactosyltransferase I (beta4-GalT I) to the Golgi apparatus by dual confocal immunostaining. Pulse/chase analysis of metabolically labeled alpha3-FucT VI showed maturation of alpha3-FucT VI from the early 43 kDa form to the mature, endoglycosidase H-resistant form of 47 kDa which was detected after 2 h of chase. alpha3-FucT VI was released to the medium and accounted for 50% of overall cell-associated and released enzyme activity. Release occurred by proteolytical cleavage which produced a soluble form of 43 kDa. Monensin treatment segregated alpha3-FucT VI from the Golgi apparatus to swollen peripheral vesicles where it was colocalized with beta4-GalT I while alpha2,6(N)sialyltransferase remained associated with the Golgi apparatus. Both constitutive secretion of alpha3-FucT VI and its monensin-induced relocation to vesicles analogous to beta4-GalT I suggest a similar post-Golgi pathway of both alpha3-FucT VI and beta4-GalT I.
机译:血浆,肝和肾中主要的α1,3岩藻糖基转移酶活性与岩藻糖基转移酶VI有关,后者由FUT6基因编码。在这里,我们通过特异性活性测定,转录本检测和特异性抗体的使用,证明了人类HepG2肝癌细胞系中存在α1、3岩藻糖基转移酶VI(α3-FucTVI)。首先,显示HepG2细胞裂解物中的FucT活性偏爱唾液酸-N-乙酰基乳糖胺作为受体底物,表明α3-FucTVI的表达。 RT-PCR分析进一步证实了迄今克隆的五种人类α3-FucT中仅存在α3-FucTVI转录本。通过双共聚焦免疫染色将alpha3-FucT VI与beta1,4半乳糖基转移酶I(beta4-GalT I)共定位到高尔基体中。代谢标记的α3-FucTVI的脉冲/追踪分析显示,α3-FucTVI从早期的43 kDa形式成熟到成熟的,内切糖苷酶H抗性形式的47 kDa(在追逐2小时后即可检测到)。 alpha3-FucT VI被释放到培养基中,占整个细胞相关和释放的酶活性的50%。通过蛋白水解切割发生释放,产生43kDa的可溶形式。莫能菌素处理从高尔基体中分离出α3-FucTVI到肿胀的外周囊泡,其中它与β4-GalTI共定位,而α2,6(N)唾液酸转移酶仍与高尔基体相关。 α3-FucTVI的组成型分泌及其莫能菌素诱导的类似于β4-GalTI的囊泡重定位均暗示了α3-FucTVI和β4-GalTI的类似高尔基后途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号